My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
WORK PLANS
EnvironmentalHealth
>
EHD Program Facility Records by Street Name
>
M
>
MAIN
>
600
>
2900 - Site Mitigation Program
>
PR0548753
>
WORK PLANS
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
7/17/2026 2:32:59 PM
Creation date
3/2/2026 11:15:39 AM
Metadata
Fields
Template:
EHD - Public
ProgramCode
2900 - Site Mitigation Program
File Section
WORK PLANS
RECORD_ID
PR0548753
PE
2959 - DTSC LEAD AGENCY SITE
FACILITY_ID
FA0027916
FACILITY_NAME
BOBSON CLEANERS, INC.
STREET_NUMBER
600
Direction
N
STREET_NAME
MAIN
STREET_TYPE
ST
City
MANTECA
Zip
95336
APN
22314117
CURRENT_STATUS
Active, billable
QC Status
Approved
Scanner
SJGOV\gmartinez
Supplemental fields
Site Address
600 N MAIN ST MANTECA 95336
Tags
EHD - Public
Jump to thumbnail
< previous set
next set >
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
616
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
Cleanup in Vulnerable Communities'Initiative Final Project Reference:Bobson Cleaners <br /> Discovery and Enforcement Discovery Project Number:60688620-5.1 <br /> Investigation Work Plan <br /> groundwater samples have been compared with the Preliminary Remediation Goals (PRGs)published by USEPA <br /> Region IX(including the Cal/EPA-modified PRGs)to verify that all MDLs are below their respective PRGs, with the <br /> exception of arsenic(typical background concentrations of arsenic in California soil are above the MDL,so the <br /> arsenic MDL is considered acceptable).The planned MDLs for soil gas samples comply with the Programmatic <br /> QAPP. <br /> 4.3 Data Collection and Evaluation <br /> The AECOM QA Manager or her/his designee will review the laboratory reports and prepare a data-review verification <br /> sheet that will be appended to the DI Report. The laboratory reports will be reviewed for the following: <br /> • Data Completeness, <br /> • Chain of Custody, <br /> • Holding Times, <br /> • Sample Preservation, <br /> • Blanks, <br /> • Laboratory Control Samples, <br /> • Matrix Spike/Matrix Spike Duplicates, <br /> • Surrogates/Internal Standards(as applicable), and <br /> • Field Quality Control Samples. <br /> Data that do not meet the DQOs set forth in Section 4.2 will be qualified and flagged. Data qualification flags will <br /> indicate whether results are considered anomalous, estimated, or rejected. Only rejected data are considered <br /> unusable for decision-making purposes; however, other qualified data may require further verification, such as <br /> reviewing the laboratory's raw data. <br /> Detection limits associated with the analytical data will be reviewed before eliminating chemicals from the human <br /> health screening evaluation because they were not detected. In some cases, the detection limit for a chemical may <br /> be greater than the corresponding standards,criteria, or concentrations derived from toxicity reference values; <br /> therefore, the chemical may be present at levels greater than these corresponding reference concentrations,which <br /> may result in undetected risk. In other cases, a particular detection limit may be significantly higher than positively <br /> detected values in other samples in a data set.After considering these cases and any other reasonable reasons why <br /> contaminants may not have been detected,chemicals that have not been detected in any medium will be eliminated if <br /> appropriate. If information exists to indicate that the chemicals are present,they will not be eliminated.The DI report <br /> will identify the possibility of undetected or non-sufficiently characterized contaminants and recommend additional <br /> sampling as part of further investigation, as appropriate. <br /> A laboratory may identify VOC and SVOC tentatively identified compounds (TICS)during sample analysis. Both the <br /> identity and reported concentration of a TIC are not definitive. Depending on the relative number of TICS compared to <br /> non-TICs, options exist to address TICS during the screening evaluation (Chapter 5, USEPA, 1989). If a significant <br /> number of TICS are identified during the investigation, the use of these data in the human health screening evaluation <br /> will be discussed with the DTSC. <br /> For analytical results,various qualifiers pertaining to the quality of the data may be assigned to certain analytical <br /> results by either the laboratory conducting the analysis or by persons conducting data review as discussed above. <br /> For example,some results may be marked as estimated if the concentration is below the verifiable or contract- <br /> required detection limit but may be detected at a lower value by the instrument.All qualified results will be reviewed <br /> prior to use of the chemical data set for the human health screening evaluation.Any data discrepancies will be <br /> reviewed and explained in the DI Report. If enough data are rejected as unusable for decision-making purposes, such <br /> that the DQO for completeness is not achieved,then corrective actions such as reanalysis or resampling will be <br /> performed,with DTSC concurrence[USEPA, 2004]. <br /> Prepared for: Department of Toxic Substances Control AECOM <br /> 26 <br />
The URL can be used to link to this page
Your browser does not support the video tag.